These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 581373)

  • 1. [Estimation of thyroid stimulating immunoglobulins (TSI) by the radioreceptor method].
    Wasilewska A; Nauman J
    Endokrynol Pol; 1978; 29(5):361-70. PubMed ID: 581373
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Studies on long-acting thyroid stimulator protector in serum containing long-acting thyroid stimulator.
    Dirmikis S; Munro DS
    J Endocrinol; 1975 Mar; 64(3):29P-30P. PubMed ID: 1173370
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical application of a radioreceptor assay for thyroid stimulators.
    Schleusener H; Kotulla P; Adlkofer F; Nussey SS; Mehdi SQ
    Horm Metab Res; 1975 Jul; 7(4):360-1. PubMed ID: 1173807
    [No Abstract]   [Full Text] [Related]  

  • 4. LATS protector and abnormal thyroid stimulation in diffuse toxic goitre.
    Stewart RD
    N Z Med J; 1975 Jan; 81(531):24. PubMed ID: 1055311
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent findings on TSH, LATS and TSI].
    Yamashita K; Kugai N
    Nihon Rinsho; 1981 Sep; 39(9):2949-53. PubMed ID: 6121923
    [No Abstract]   [Full Text] [Related]  

  • 6. Isoelectric focusing of long-acting thyroid stimulator (LATS) containing IgG.
    Schleusener H; Adlkofer F; Uher L; Kaper-Czygan S; Kirstaedter HJ
    Horm Metab Res; 1971 May; 3(3):221-2. PubMed ID: 5171402
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)].
    Studer H
    Schweiz Med Wochenschr; 1967 May; 97(19):622-3. PubMed ID: 5632362
    [No Abstract]   [Full Text] [Related]  

  • 8. [Standardization of the radiobiological method for determination of long-acting thyroid stimulator (LATS) in human serum].
    Muramoto E; Nicolau W; Ikeda E; de Assis LM; Pieroni RR
    AMB Rev Assoc Med Bras; 1972 Oct; 18(10):379-88. PubMed ID: 4539360
    [No Abstract]   [Full Text] [Related]  

  • 9. [Concentration of plasma in hyperthyroid patients for the detection of G immunoglobulins with LATS activity].
    Orgiazzi J; Rousset B; Mornex R
    Ann Endocrinol (Paris); 1972; 33(2):139-47. PubMed ID: 4678454
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.
    Lipman LM; Green DE; Snyder NJ; Nelson JC; Solomon DH
    Am J Med; 1967 Oct; 43(4):486-98. PubMed ID: 6072779
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
    Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
    J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thyroid acropachy with an abnormally high concentration of long acting thyroid stimulator].
    Momotani N; Suzuki T; Harada S; Nishikawa Y; Ito K
    Horumon To Rinsho; 1972 Aug; 20(8):649-53. PubMed ID: 4678862
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
    Sawhney RC; Kannan V; Rastogi GK
    J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
    [No Abstract]   [Full Text] [Related]  

  • 14. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
    Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M
    J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
    McKenzie JM; McCullagh EP
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
    [No Abstract]   [Full Text] [Related]  

  • 16. [LATS and Graves' disease].
    Gordon A
    Harefuah; 1971 May; 80(10):569-70. PubMed ID: 5171988
    [No Abstract]   [Full Text] [Related]  

  • 17. [Simultaneous determination of thyreotropic hormone and long-acting thyroid stimulator in the plasma of Basedow patients].
    Földes J; Gesztesi E; Takács I
    Orv Hetil; 1970 Dec; 111(52):3067-70. PubMed ID: 4099957
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radioreceptor assay of TSH].
    Torizuka K; Konishi J; Endo K; Ikekubo K; Mori T
    Nihon Rinsho; 1976; 34(3):471-6. PubMed ID: 778435
    [No Abstract]   [Full Text] [Related]  

  • 20. Validation of cytochemical section bioassay for thyroid-stimulating immunoglobulins in treated and untreated Graves' disease.
    Prentice MG; Alaghband-Zadeh J; Wise PH
    J Immunoassay; 1984; 5(3-4):275-90. PubMed ID: 6549396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.